Mesenchymal Stem Cells (Masonic Cancer Center, University Of Minnesota)

N/A

Report date: 2025/07/29 20:00:11

Base Information

Drug NameMesenchymal Stem Cells (Masonic Cancer Center, University Of Minnesota)

Drug Alias NameMesenchymal stem cell transplantation (Masonic Cancer Center, University Of Minnesota)Donor mesenchymal stem cell infusions (Masonic Cancer Center, University Of Minnesota)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAdrenoleukodystrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMasonic Cancer Center, University Of Minnesota

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMasonic Cancer Center, University Of Minnesota

Active IndicationsN/A

Inactive IndicationsAdrenoleukodystrophy

Other Information

ATC CodeN/A